Subcutaneous APL-2: Phase I data

Data from a pair of double-blind, placebo-controlled, Australian Phase I trials in a

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE